An automated peritoneal dialysis system provides various features including prescription-driven dialysis fluid preparation, an integrated disposable fluid circuit, and sensor capabilities that allow accurate filing and draining control with high safety margins. Features include a peritoneal fluid circuit with a pressure sensor at either end and methods and devices for using the pressure signals. Other features and embodiments are disclosed.

An apparatus for ultrafiltration of a patient being overhydrated due to congestive heart failure, comprising a tube set including a connector (21) for connection to a patient line (3) for access to the peritoneal cavity of the patient. A flow pump (41-43) is arranged for addition and removal outflow and inflow (recirculation) of fluid from/to the peritoneal cavity. An osmotic agent peristaltic pump (16) is arranged for replenishment of glucose solution to the fluid added to the peritoneal cavity for promoting ultrafiltration. The glucose is replenished intermittently for keeping a concentration of glucose substantially constant in the peritoneal cavity. The flow pump comprises a pressure chamber (43) with rigid walls and a flexible pump bag (41) arranged therein. An air pump (45) pressurizes the chamber for outflow of fluid from the peritoneal cavity by a sub pressure and inflow of fluid to the peritoneal cavity by an overpressure, which pressures are maintained within safe limits.

Systems and method for monitoring the glucose concentration of a patient during a peritoneal dialysis session, and automated administration of a medication in response to the glucose concentration falling outside a specified range. The system includes a peritoneal dialysis system, a glucose sensor and at least one medication infusion pump. The peritoneal dialysis system includes a control system, and a peritoneal dialysate generation flow path fluidly connectable to a patient. The glucose sensor is in communication with the control system and positioned to continuously measure the glucose concentration of the patient during the peritoneal dialysis session. The control system can be programmed to provide automated administration of medication by the at least one medication infusion pump in response to changes in the glucose concentration of the patent during the hemodialysis session.

A security token is provided having a communication interface with a communication transceiver; a circuit having encoded thereon an immutable hardware key; and a tangible, nonvolatile memory, the nonvolatile memory having stored thereon a mutable software key, the mutable software key including a cryptographic key and an expiry for the cryptographic key.

A dialysis machine operable with a disposable set having at least one container, the dialysis machine including a pump actuator operable to pump dialysis fluid to and/or from the at least one container; a weigh plate positioned to support the at least one container; a plurality of operational load cells positioned to support the weigh plate; a linear actuator positioned to apply a force to the weigh plate; a calibration load cell positioned to measure the force applied by the linear actuator; and a control unit in operable communication with the operational load cells, the linear actuator and the calibration load cell, the control unit configured to cause the linear actuator to apply the force to the weigh plate, compare resulting outputs from the operational load cells and the calibration load cell, and determine a calibration factor from the comparison for offsetting future outputs from the operational load cells.

Systems and methods for performing Direct Sodium Removal (DSR) therapy are provided in which an implantable device includes a pump coupled to an inlet catheter designed for placement in a patient's peritoneal cavity, an outlet catheter designed to be coupled to the patient's bladder, and is operably coupled to an analyte sensor, the pump programmed to transfer and/or cease transfer of fluid from the patient's peritoneal cavity to the patient's bladder for voiding responsive to a level of analyte detected by the analyte sensor. In addition, the system may include a processor that computes an amount of analyte transferred per pumping session.

The disclosure relates to systems, devices, and methods for sensing the volume of liquid in a container, such as within a medical device. The systems, devices, and methods can measure the properties of a signal sent across a container using non-intrusive components that remain outside the container. The measured properties can be used to determine the volume of liquid in the container, as well as changes to the volume of liquid representing flow into and out of the container.

A peritoneal dialysis machine having a machine housing and having a heating receiver as well as having a plurality of solution bags is provided. The peritoneal dialysis machine furthermore has a hose set which is connected to the solution bags, wherein the plurality of solution bags are arranged in the heating pan and wherein the hose set does not have any heating bag into which the liquid draining from the solution bags runs.

Methods, apparatuses, and systems for determining a correlation between intraperitoneal pressure (“IPP”) measurements and patient intraperitoneal volume (“IPV”) are disclosed. In an example, an apparatus is configured to determine a maximum fill volume of dialysate to be pumped into a peritoneal cavity of a patient. The apparatus also determines a plurality of iterations to achieve the maximum fill volume and a volume of the dialysate to be pumped for each of the iterations. For each iteration, the apparatus causes a dialysis machine to pump the dialysate to the peritoneal cavity based on the determined volume for that iteration, records IPP measurement output data from a pressure sensor, records or determines a total accumulated fill volume, and creates a data point for a personalized patient model corresponding to a correlation between the IPP measurement output data and the total accumulated fill volume.

A Direct Sodium Removal method, apparatus and solution for treating patients in heart failure, and having a glomerular filtration rate greater than 15 mL/min/1.73 m.sup.2, or residual kidney function corresponding to normal to CKD Stage 4, is provided in which a no or low sodium DSR infusate is administered to the peritoneal cavity for a predetermined dwell period and then removed, thereby removing sodium from the body. The resulting elimination of fluid from the patient by i) functioning of the kidneys through urination and ii) direct removal of osmotic ultrafiltrate from the peritoneal cavity, restores serum sodium concentrations to healthy levels and thereby reduces fluid overload in the patient.